Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-trace').style.display = (document.getElementById('cakeErr67eeef20de4af-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67eeef20de4af-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-code').style.display = (document.getElementById('cakeErr67eeef20de4af-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-context').style.display = (document.getElementById('cakeErr67eeef20de4af-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67eeef20de4af-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67eeef20de4af-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26610,
		&#039;title&#039; =&gt; &#039;Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674648,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26610,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Access to Medicines,medicine,medicines,healthcare,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26610,
	&#039;title&#039; =&gt; &#039;Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674648,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26610
$metaTitle = &#039;LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;
$metaKeywords = &#039;Access to Medicines,medicine,medicines,healthcare,Health&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Overdependence on China for drug ingredients worries NSA -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.</p><p align="justify">According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.</p><p align="justify">&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.</p><p align="justify">Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.</p><p align="justify">In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.</p><p align="justify">Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.</p><p align="justify">The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.</p><p align="justify">India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.</p><p align="justify">The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.</p><p align="justify">However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-trace').style.display = (document.getElementById('cakeErr67eeef20de4af-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67eeef20de4af-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-code').style.display = (document.getElementById('cakeErr67eeef20de4af-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-context').style.display = (document.getElementById('cakeErr67eeef20de4af-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67eeef20de4af-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67eeef20de4af-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26610,
		&#039;title&#039; =&gt; &#039;Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674648,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26610,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Access to Medicines,medicine,medicines,healthcare,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26610,
	&#039;title&#039; =&gt; &#039;Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674648,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26610
$metaTitle = &#039;LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;
$metaKeywords = &#039;Access to Medicines,medicine,medicines,healthcare,Health&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Overdependence on China for drug ingredients worries NSA -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.</p><p align="justify">According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.</p><p align="justify">&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.</p><p align="justify">Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.</p><p align="justify">In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.</p><p align="justify">Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.</p><p align="justify">The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.</p><p align="justify">India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.</p><p align="justify">The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.</p><p align="justify">However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-trace').style.display = (document.getElementById('cakeErr67eeef20de4af-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67eeef20de4af-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-code').style.display = (document.getElementById('cakeErr67eeef20de4af-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eeef20de4af-context').style.display = (document.getElementById('cakeErr67eeef20de4af-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67eeef20de4af-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67eeef20de4af-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26610,
		&#039;title&#039; =&gt; &#039;Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674648,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26610,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Access to Medicines,medicine,medicines,healthcare,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26610,
	&#039;title&#039; =&gt; &#039;Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674648,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26610
$metaTitle = &#039;LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey&#039;
$metaKeywords = &#039;Access to Medicines,medicine,medicines,healthcare,Health&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&amp;quot; a senior official in the government privy to the developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &amp;quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&amp;quot; the official said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India&#039;s Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Overdependence on China for drug ingredients worries NSA -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.</p><p align="justify">According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.</p><p align="justify">&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.</p><p align="justify">Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.</p><p align="justify">In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.</p><p align="justify">Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.</p><p align="justify">The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.</p><p align="justify">India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.</p><p align="justify">The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.</p><p align="justify">However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26610,
		'title' => 'Overdependence on China for drug ingredients worries NSA -Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
</p>
<p align="justify">
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
</p>
<p align="justify">
&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.
</p>
<p align="justify">
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
</p>
<p align="justify">
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
</p>
<p align="justify">
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.
</p>
<p align="justify">
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
</p>
<p align="justify">
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
</p>
<p align="justify">
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
</p>
<p align="justify">
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
</p>',
		'credit_writer' => 'The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674648,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26610,
	'metaTitle' => 'LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey',
	'metaKeywords' => 'Access to Medicines,medicine,medicines,healthcare,Health',
	'metaDesc' => '
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.</p><p align="justify">According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.</p><p align="justify">&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.</p><p align="justify">Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.</p><p align="justify">In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.</p><p align="justify">Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.</p><p align="justify">The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.</p><p align="justify">India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.</p><p align="justify">The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.</p><p align="justify">However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26610,
	'title' => 'Overdependence on China for drug ingredients worries NSA -Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.
</p>
<p align="justify">
According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.
</p>
<p align="justify">
&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.
</p>
<p align="justify">
Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.
</p>
<p align="justify">
In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.
</p>
<p align="justify">
Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.
</p>
<p align="justify">
The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.
</p>
<p align="justify">
India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.
</p>
<p align="justify">
The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.
</p>
<p align="justify">
However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.
</p>',
	'credit_writer' => 'The Times of India, 26 November, 2014, http://timesofindia.indiatimes.com/india/Overdependence-on-China-for-drug-ingredients-worries-NSA/articleshow/45278715.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'overdependence-on-china-for-drug-ingredients-worries-nsa-sushmi-dey-4674648',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674648,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26610
$metaTitle = 'LATEST NEWS UPDATES | Overdependence on China for drug ingredients worries NSA -Sushmi Dey'
$metaKeywords = 'Access to Medicines,medicine,medicines,healthcare,Health'
$metaDesc = '
-The Times of India


NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.


According to...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt.</p><p align="justify">According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature.</p><p align="justify">&quot;The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations,&quot; a senior official in the government privy to the developments, told TOI.</p><p align="justify">Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country.</p><p align="justify">In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries.</p><p align="justify">Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. &quot;The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO,&quot; the official said.</p><p align="justify">The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances.</p><p align="justify">India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import.</p><p align="justify">The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%.</p><p align="justify">However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Overdependence on China for drug ingredients worries NSA -Sushmi Dey

-The Times of India NEW DELHI: India runs the risk of a severe shortage of medicines because of its over dependence on China for sourcing raw material for drugs, national security adviser (NSA) Ajit Doval has warned, TOI has learnt. According to the NSA, India should take immediate concrete steps to create adequate infrastructure to become self-sufficient for manufacturing medicines which are essential in nature. "The national security adviser had highlighted concerns related to overdependence on China for supply of active pharmaceutical ingredient (API). Following this, a core committee of experts was formed under the health ministry and a policy would soon be finalized to boost domestic manufacturing of bulk drugs used in medicine formulations," a senior official in the government privy to the developments, told TOI. Currently, India imports over 80-85% of API, or raw material used in medicines, from China. This is crucial because any kind of tension or adverse circumstances between the two countries have potential to lead to a crisis in public health in India. Experts say China has antagonized many of its neighbours in the past and India should take a call based on its economic and strategic relationship with the country. In 2010, the Chinese government had blocked exports to Japan of a crucial category of minerals used in products like hybrid cars, wind turbines and guided missiles, following tensions between the two countries. Sources said the PMO as well as health ministry had taken cognizance of the issue. To start with, the government is set to roll out a separate policy to revive the domestic API manufacturing industry. "The committee and task force set up by the government for preparing the policy have finalized their recommendations and gone to the PMO," the official said. The proposed policy will address the concerns of bulk drug manufacturing by way of incentives and creating infrastructure through bulk drug parks, etc. The proposal will also evaluate other issues related to anti-dumping duties and environmental clearances. India was once a favoured destination for sourcing low-cost, good quality raw material for manufacturing medicines. However, China has taken over this bulk drug market globally in the past few years by creating huge capacities. Now, while some pharmaceutical companies manufacture selective API for captive usage, most of it is imported from China. The reason is that landed price of API from China in India is 15-20% less than its production cost here, making it more viable for companies to import. The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's Rs 79,000-crore pharmaceutical market. The rest comprises formulations. In 2007, when the total domestic pharma market was around Rs 35,000 crore, APIs accounted for over 15-20%. However, some believe price benefit is just one reason. Concerns such as environmental obstacles and lack of infrastructure dissuade domestic manufacturers. The idea is to facilitate the industry by ensuring adequate power and water supply, providing logistics and helping companies in capacity building to bring down cost of production.